Substituted benzazoles and use thereof as RAF kinase inhibitors

Details for Australian Patent Application No. 2003226211 (hide)

Owner Chiron Corporation

Inventors Ramurthy, Savithri; Levine, Barry Haskell; Poon, Daniel J.; Sung, Leonard; Amiri, Payman; Fantl, Wendy; Renhowe, Paul A.; Subramanian, Sharadha

Agent FB Rice

Pub. Number AU-B-2003226211

PCT Number PCT/US03/10117

PCT Pub. Number WO2003/082272

Priority 60/369,066 29.03.02 US

Filing date 31 March 2003

Wipo publication date 13 October 2003

Acceptance publication date 29 May 2008

International Classifications

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61K 31/4725 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/369,066 29.03.02 US

20 November 2003 Application Open to Public Inspection

  Published as AU-B-2003226211

29 May 2008 Application Accepted

  Published as AU-B-2003226211

12 June 2008 Assignment before Grant

  Chiron Corporation The application has been assigned to Novartis Vaccines and Diagnostics, Inc.

25 September 2008 Standard Patent Sealed

27 November 2008 Alteration of Name

  The name of the patentee has been altered to Novartis Vaccines and Diagnostics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003226212-MODULAR SPEAKER CONSTRUCTION

2003226210-GUTTER PUNCH